Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 01 2019
Historique:
received: 03 05 2018
accepted: 21 11 2018
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 23 1 2020
Statut: epublish

Résumé

Physio-pathologic interrelationships between endothelial layer and graft-versus-host disease (GVHD) have been described leading to assess the entity "endothelial GVHD" as the early step for clinical manifestations of acute GVHD. The availability of the CellSearch system has allowed us to monitor Circulating Endothelial Cells (CEC) changes in allogeneic hematopoietic stem cell transplantation (allo-HSCT) as useful tool to help clinicians in GVHD diagnostic definition. We have compared CEC counts generated by an ad hoc designed polychromatic-flowcytometry (PFC) Lyotube with those of the CellSearch system. CEC were counted in parallel at 5 timepoints in 50 patients with malignant hematologic disorders undergoing allo-HSCT (ClinicalTrials.gov, NCT02064972). Spearman rank correlation showed significant association between CEC values at all time points (p = 0.0001). The limits of agreement was demonstrated by Bland Altman plot analysis, showing bias not significant at T1, T3, T4, while at T2 and T5 resulted not estimable. Moreover, Passing Bablok regression analysis showed not significant differences between BD Lyotube and CellSearch system. We show that CEC counts, generated with either the CellSearch system or the PFC-based panel, have a superimposable kinetic in allo-HSCT patients and that both counting procedures hold the potential to enter clinical routine as a suitable tool to assist clinicians in GVHD diagnosis.

Identifiants

pubmed: 30643152
doi: 10.1038/s41598-018-36442-9
pii: 10.1038/s41598-018-36442-9
pmc: PMC6331628
doi:

Banques de données

ClinicalTrials.gov
['NCT02064972']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

87

Références

N Engl J Med. 2003 Feb 13;348(7):593-600
pubmed: 12584367
Transplantation. 2014 Oct 15;98(7):706-12
pubmed: 25119132
Blood. 2013 Jan 24;121(4):585-94
pubmed: 23165480
Thromb Haemost. 2006 Jul;96(1):45-52
pubmed: 16807650
Cancer Control. 2011 Oct;18(4):268-76
pubmed: 21976245
Bone Marrow Transplant. 2016 Feb;51(2):172-5
pubmed: 26551780
Bone Marrow Transplant. 2017 Sep;52(9):1317-1325
pubmed: 28650450
J Immunol Methods. 2010 May 31;357(1-2):38-42
pubmed: 20381496
Sci Rep. 2018 Apr 11;8(1):5823
pubmed: 29643468
Clin Cancer Res. 2009 Jan 1;15(1):267-73
pubmed: 19118054
Nat Rev Immunol. 2012 May 11;12(6):443-58
pubmed: 22576252
Cardiovasc Res. 2010 Jul 1;87(1):12-21
pubmed: 20427336
Blood. 2012 Jan 5;119(1):296-307
pubmed: 22010102
Curr Stem Cell Res Ther. 2010 Dec;5(4):294-302
pubmed: 20528750
Cytometry A. 2007 Feb;71(2):105-13
pubmed: 17226859
Science. 1997 Feb 14;275(5302):964-7
pubmed: 9020076
Circ Res. 2012 Feb 17;110(4):624-37
pubmed: 22343557
Bone Marrow Transplant. 2011 Dec;46(12):1495-502
pubmed: 21460864
Atherosclerosis. 2016 Aug;251:373-380
pubmed: 27255499
Cytometry A. 2016 Mar;89(3):259-70
pubmed: 26305912
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Bone Marrow Transplant. 2013 Jun;48(6):755-60
pubmed: 22863728
PLoS One. 2017 Apr 10;12(4):e0172800
pubmed: 28394933
Eur J Haematol. 2000 Oct;65(4):215-20
pubmed: 11073162
J Thromb Haemost. 2008 May;6(5):869-76
pubmed: 18284598
Bone Marrow Transplant. 2017 Dec;52(12):1637-1642
pubmed: 28892085
J Thromb Haemost. 2012 May;10(5):931-9
pubmed: 22385979
Br J Haematol. 2012 Jul;158(1):30-45
pubmed: 22533831
Sci Transl Med. 2012 Mar 21;4(126):126ra33
pubmed: 22440735
N Engl J Med. 2007 Oct 11;357(15):1472-5
pubmed: 17928594
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
Lancet. 2002 Jun 15;359(9323):2078-83
pubmed: 12086762

Auteurs

Camillo Almici (C)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy. camillo.almici@asst-spedalicivili.it.

Arabella Neva (A)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy.

Cristina Skert (C)

Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy.

Benedetto Bruno (B)

BMT Unit, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy.

Rosanna Verardi (R)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy.

Andrea Di Palma (A)

Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy.

Andrea Bianchetti (A)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy.

Simona Braga (S)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy.

Giovanna Piovani (G)

Biology and Genetics Division, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Valeria Cancelli (V)

Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy.

Paola Omedè (P)

BMT Unit, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy.

Kurt Baeten (K)

Global Scientific and Medical Affairs, Janssen Diagnostics, Beerse, Belgium.

Gianluca Rotta (G)

Scientific Affairs, BD Biosciences Italia, Milano, Italy.

Domenico Russo (D)

Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy.

Mirella Marini (M)

Laboratory for Stem Cells Manipulation and Cryopreservation, Dpt of Transfusion Medicine, ASST Spedali Civili, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH